The NGS sample preparation market is witnessing an uptick owing to factors such as favorable government initiatives, increasing public-private investments in the field of next-generation sequencing, and the rising cancer incidences. For instance, in America, nearly 1.9 million new cancer cases was expected to be diagnosed in 2021. Approximately 608,570 Americans are expected to die of cancer in 2021, which translates to about 1,670 deaths per day. This has attracted the focus of many biotechnology companies on developing sequencing solutions for different applications such as translational research and diagnostics which will further support the researchers and clinicians to unravel insights on disease manifestation and progression. Thereby, boosting the NGS sample preparation market.

Get the inside scoop with Sample report - https://univdatos.com/get-a-free-sample-form-php/?product_id=19541

Genome sequencing is a widely used method to understand the evolution and spread of coronavirus across the globe. As of March 16, 2021, there have been almost 121 million cases of COVID-19 worldwide. The disease has impacted more than 210 countries and territories, with the United States confirming around one-fifth of all global cases. Therefore, it has become imperative to decipher the transmission chain of the virus which in turn will help in controlling the spread of this virus. Owing to these facts, many government agencies and public health institutions have geared up to fight against this virus with the help of sequencing. For instance, Recently, in March 2020, the COVID-19 genomics U.K. consortium (COG-U.K.) was performed to study the coronavirus genome by using whole-genome sequencing.

According to UnivDatos Market Insights (UMI)’ research report “Global NGS sample preparation Analysis, 2020”, the NGS sample preparation market is projected to grow at a CAGR of around 15% during 2021-27F. Promulgating strategic alliances among industry players and growing advancement in NGS technologies which can be used in different areas of biomedical, basic research and agriculture are other factors that are significantly driving the NGS sample preparation market globally. For example, in June 2020, 10x Genomics, Inc. and Merck collaborated for providing impactful linking of two innovative technologies: single-cell transcriptomics and pooled CRISPR screening to the researchers which will provide more detailed information to them for understanding the relationship between specific genes and disease.

Download Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=19541

Based on the application, the market is fragmented into disease diagnostics, drug discovery, and agriculture and animal research. The disease diagnostics segment accounted for a considerable share in 2020 and is anticipated to register a lucrative CAGR during the forecast period. The growth of this segment is attributed to the growing prevalence of various diseases such as cancer, infectious, and other rare diseases. For instance, according to the World Health Organization, more than 13 million people die from infectious diseases each year. Further, in some developing countries, it leads to 1 in 2 deaths annually.

Academic Institutes and Research Centers Segment to Witness Robust growth

Based on end-users, the market is segmented into academic institutes and research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end-users. The academic institutes and research centers segment had the highest revenue and CAGR growth in the analyzed period owing to the promulgating strategic alliances between NGS market players and academic & research centers and the availability of funds for genomics R&D across the globe.

North America to Grab Lion’s Share, and Asia-Pacific witnessed Explicit Growth

Based on the region, North America dominated the global NGS Sample Preparation market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of a well-established healthcare infrastructure and growing adoption of advanced diagnostics systems in the region. Asia-Pacific is expected to skyrocket with a CAGR of X% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global NGS Sample Preparation Market Analysis, 2020”. 

For more informative information, please visit us – https://univdatos.com/report/ngs-sample-preparation-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the NGS Sample Preparation Market include Becton, Dickinson and Company, Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc., Beckman Coulter, Pacific Biosciences of California, Promega Corporation, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global NGS Sample Preparation Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for NGS sample preparation providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/ngs-sample-preparation-market/

Market Segmentation:

1.     By Product (Workstations and Reagents & Consumables)

2.     By Library Preparation (DNA, RNA, Target Enrichment, and Quality Control)

3.     By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, and Other)

4.     By Application (Disease Diagnostics, Drug Discovery, and Agriculture & Animal Research)

5.     By End-Users (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other)

6.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

7.     By Company (Becton, Dickinson and Company, Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc., Beckman Coulter, Pacific Biosciences of California, Promega Corporation, etc.)

Key questions answered in the study:

1.     What are the current and future trends of the NGS sample preparation industry?

2.     How the industry has been evolving in terms of technology, product, library preparation, application, and end-users?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the NGS sample preparation industry?

5.     What is the customer orientation, purchase behavior, and expectations from NGS sample preparation firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL NGS SAMPLE PREPARATION MARKET COVID-19 IMPACT

6 GLOBAL NGS SAMPLE PREPARATION MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

8 MARKET INSIGHTS BY LIBRARY PREPARATION

9 MARKET INSIGHTS BY TECHNOLOGY

10 MARKET INSIGHTS BY APPLICATION

11 MARKET INSIGHTS BY END-USERS

12 MARKET INSIGHTS BY REGION

13 NGS SAMPLE PREPARATION MARKET DYNAMICS

14 NGS SAMPLE PREPARATION MARKET OPPORTUNITIES

15 NGS SAMPLE PREPARATION MARKET TRENDS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

20 COMPANY PROFILED

21 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Kyphoplasty Market to Reach US$ 3.2 Billion by 2027 Globally | CAGR: 14.5% |

·       Defibrillator Market to Reach US$ 15.5 Billion by 2027 Globally |CAGR: 5.3%|

·       3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% |

·       Gene Therapy Market to Reach US$ 20.9 Billion by 2027, Globally |CAGR: 29.7%|

 About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Web: https://univdatos.com

Ph: +91 7838604911